Home > Boards > US Listed > Biotechs >

Travere Therapeutics, Inc. (TVTX)

TVTX RSS Feed
Add TVTX Price Alert      Hide Sticky   Hide Intro
Moderator: cash4
Search This Board: 
Last Post: 2/5/2021 12:12:11 AM - Followers: 0 - Board type: Free - Posts Today: 0

 

TVTX

Travere Therapeutics, Inc.

http://www.retrophin.com/
 
DESCRIPTION
Retrophin, Inc. (OTCQB: RTRX) New York-based, biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. Retrophin is currently developing treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy (DMD), and Spinal Muscular Atrophy (SMA).
 
 
TVTX SECURITY DETAILS

Share Structure

 
 
Market Cap Market Cap
1,547,540,059
02/03/2021
Authorized Shares
100,000,000
03/05/2013
Outstanding Shares
50,905,923
07/29/2020
Restricted
Not Available
 
Unrestricted
Not Available
 
Held at DTC
Not Available
 
Float
8,280,000
03/05/2013
Par Value
0.0001
 

TRAVERE THERAPEUTICS, INC.

3611 Valley Centre Drive

Suite 300

San Diego, CA 92130

TVTX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TVTX News: Travere Therapeutics Recognizes Rare Disease Day 2021 and the Importance of Working Together to Innovate and Address Healthc... 02/25/2021 08:00:00 AM
TVTX News: Travere Therapeutics to Present at Upcoming Investor Conferences 02/22/2021 04:30:00 PM
TVTX News: Statement of Changes in Beneficial Ownership (4) 02/18/2021 06:26:51 PM
TVTX News: Travere Therapeutics Announces European Commission Has Granted Orphan Designation to Sparsentan for the Treatment of IgA Neph... 02/18/2021 04:30:00 PM
TVTX News: Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option t... 02/17/2021 04:05:00 PM
PostSubject
#1   Free Martin Shkreli, LMFAO, felon CEO with a cash4 02/05/21 12:12:11 AM
PostSubject
Consent Preferences